Corey Davis
Stock Analyst at HC Wainwright & Co.
(2.56)
# 2,216
Out of 4,670 analysts
18
Total ratings
66.67%
Success rate
9.83%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Corey Davis
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| NKTR Nektar Therapeutics | Reiterates: Neutral | $32 → $26 | $1.05 | +2,376.19% | 5 | May 12, 2020 | |
| SCYX SCYNEXIS | Assumes: Buy | $50 | $1.20 | +4,066.67% | 3 | May 7, 2018 | |
| VTVT vTv Therapeutics | Downgrades: Neutral | $560 → $40 | $14.18 | +182.09% | 2 | Apr 10, 2018 | |
| LPCN Lipocine | Initiates: Buy | $170 | $5.15 | +3,200.97% | 1 | Mar 29, 2018 | |
| VNDA Vanda Pharmaceuticals | Initiates: Buy | $20 | $5.09 | +292.93% | 2 | Jan 19, 2018 | |
| PCRX Pacira BioSciences | Initiates: Buy | $50 | $17.55 | +184.90% | 3 | Jan 19, 2018 | |
| CARA Cara Therapeutics | Initiates: Buy | $27 | $0.31 | +8,749.56% | 1 | Jan 19, 2018 | |
| JAZZ Jazz Pharmaceuticals | Initiates: Neutral | $144 | $126.67 | +13.68% | 1 | Aug 25, 2017 |
Nektar Therapeutics
May 12, 2020
Reiterates: Neutral
Price Target: $32 → $26
Current: $1.05
Upside: +2,376.19%
SCYNEXIS
May 7, 2018
Assumes: Buy
Price Target: $50
Current: $1.20
Upside: +4,066.67%
vTv Therapeutics
Apr 10, 2018
Downgrades: Neutral
Price Target: $560 → $40
Current: $14.18
Upside: +182.09%
Lipocine
Mar 29, 2018
Initiates: Buy
Price Target: $170
Current: $5.15
Upside: +3,200.97%
Vanda Pharmaceuticals
Jan 19, 2018
Initiates: Buy
Price Target: $20
Current: $5.09
Upside: +292.93%
Pacira BioSciences
Jan 19, 2018
Initiates: Buy
Price Target: $50
Current: $17.55
Upside: +184.90%
Cara Therapeutics
Jan 19, 2018
Initiates: Buy
Price Target: $27
Current: $0.31
Upside: +8,749.56%
Jazz Pharmaceuticals
Aug 25, 2017
Initiates: Neutral
Price Target: $144
Current: $126.67
Upside: +13.68%